Department of Endocrinology and Metabolism, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China.
National Metabolic Management Center, Shanghai, 200072, China.
Cell Death Dis. 2021 Feb 26;12(2):221. doi: 10.1038/s41419-021-03512-2.
Gastric mucosal injury is a less well known complication of obesity. Its mechanism remains to be further elucidated. Here, we explored the protective role of lipocalin 2 (LCN2) against endoplasmic reticulum stress and cell apoptosis in gastric mucosa in patients and mice with obesity. Through molecular and genetic analyses in clinical species, LCN2 secreted by parietal cells expression is elevated in obese. Immunofluorescence, TUNEL, and colorimetry results show that a more significant upregulation of pro-inflammatory factors and increased amount of apoptotic cells in gastric tissue sections in obese groups. Loss- and gain-of-function experiments in gastric epithelial cells demonstrate that increased LCN2 protected against obesity associated gastric injury by inhibiting apoptosis and improving inflammatory state. In addition, this protective effect was mediated by repressing ER stress. Our findings identify LCN2 as a gastric hormone could be a compensatory protective factor against gastric injury in obese.
胃黏膜损伤是肥胖的一种不太为人知的并发症。其机制仍有待进一步阐明。在这里,我们探讨了脂肪素 2(LCN2)在肥胖患者和小鼠的胃黏膜中对抗内质网应激和细胞凋亡的保护作用。通过临床物种的分子和遗传分析,发现壁细胞分泌的 LCN2 在肥胖患者中升高。免疫荧光、TUNEL 和比色法结果表明,肥胖组胃组织切片中促炎因子的上调更为显著,凋亡细胞数量增加。胃上皮细胞的缺失和功能获得实验表明,增加的 LCN2 通过抑制细胞凋亡和改善炎症状态来抵抗肥胖相关的胃损伤。此外,这种保护作用是通过抑制内质网应激来介导的。我们的研究结果表明,LCN2 作为一种胃激素,可能是肥胖患者胃损伤的一种代偿性保护因素。